Position
Chief Business Officer
Company
Alchemab Therapeutics
LondonBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Alchemab Therapeutics has appointed Ulrich Wendt, PhD MBA, as Chief Business Officer to expand partnerships with biopharma for the development of novel antibody therapeutics. Dr. Wendt will lead the company's business development and alliance management efforts.
Quick answer
Alchemab Therapeutics Appoints Ulrich Wendt as Chief Business Officer (March 17, 2026). Alchemab Therapeutics is based in London, England, United Kingdom.
- Who is the new Chief Business Officer at Alchemab Therapeutics?
- Alchemab Therapeutics named Ulrich Wendt Chief Business Officer, announced March 17, 2026.
- What did Alchemab Therapeutics announce on March 17, 2026?
- Alchemab Therapeutics has appointed Ulrich Wendt, PhD MBA, as Chief Business Officer to expand partnerships with biopharma for the development of novel antibody therapeutics. Dr. Wendt will lead the company's business development and alliance management efforts.
- What does Alchemab Therapeutics do?
- Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.
- Where is Alchemab Therapeutics based?
- Alchemab Therapeutics is based in London, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Atossa Therapeutics (March 19, 2026), Aquestive Therapeutics, Inc. (March 20, 2026), Ratio Therapeutics (March 12, 2026) and Aurinia Pharma (March 23, 2026) also announced leadership changes within 45 days of Alchemab Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Atossa Therapeutics Appoints Kathy Puyana Theall and Adebola Giwa as Medical Directors (March 19, 2026)
- Aquestive Therapeutics Announces Departure of Chief Legal Officer (March 20, 2026)
- Ratio Therapeutics Appoints Colin Hayward as Chief Medical Officer (March 12, 2026)
- Aurinia Pharmaceuticals Appoints Kevin Tang as Chief Executive Officer and Ryan Cole as Chief Operating Officer (March 23, 2026)
- MBX Biosciences Appoints Karen Basbaum as Chief Business Officer (March 10, 2026)
- Santhera Pharmaceuticals Appoints Marc Clausse as Chief Commercial Officer (March 10, 2026)
Who to call at Alchemab Therapeutics, and when
A new leader at Alchemab Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Alchemab Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alchemab Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alchemab Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alchemab Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alchemab Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.